Autonomix Medical, Inc.

Q: Jun 30 2026

FY: Mar 31 2026

FY: Mar 31 2026

Q: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

FY: Mar 31 2025

FY: Mar 31 2025

Q: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

FY: Mar 31 2024

FY: Mar 31 2024

Q: Dec 31 2023

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Other Events

Entry into a Material Definitive Agreement

Other Events

Material Modifications to Rights of Security Holders

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Other Events

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

2.02,9.01

8.01

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Amended Initial Registration Statement

Prospectus Supplement for Primary Offering

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Smith Trent N.

Bisson Lori

Hauser Bradley

KLEMP WALTER V

Cavalry Fund I LP

BioStar Ventures III, L.P.

Smith Trent N.

Hauser Bradley

Capelli Christopher

KLEMP WALTER V

Bisson Lori

CVI Investments, Inc.

Cavalry Fund I LP

CVI Investments, Inc.

BioStar Ventures III, L.P.

Robins David Andrew

Bisson Lori

KLEMP WALTER V

Smith Trent N.

BioStar Ventures III, L.P.

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Offering circular under Regulation A (Rule 253(g)(2))

No description available

No description available

Offering circular under Regulation A (Rule 253(g)(2))

Semiannual Report or Special Financial Report Pursuant to Regulation A

Offering circular under Regulation A (Rule 253(g)(2))

No description available

Regulation A Offering Statement (amendment)

Correspondence with the SEC

Regulation A Offering Statement (amendment)